Chronisch immunvermittelte Neuropathien – Diagnostik und Therapie

Die Diagnose einer immunvermittelten Neuropathie ist eine der wichtigsten Differenzialdiagnosen bei Polyneuropathien. Chronisch inflammatorische Neuropathien haben oft eine schwere neurologische Beeinträchtigung zur Folge, weswegen eine frühzeitige Diagnose zur Einleitung einer antientzündlichen Therapie essenziell ist. Therapiekonzepte beinhalten je nach Pathologie Immunglobuline, Kortikosteroide oder Plasmaaustauschverfahren.

• Literatur

• 1 Latov N. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Nat Rev Neurol 2014; 10: 435-446
• 2 Dalakas MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol 2011; 7: 507-517
• 3 Lewis RA. Chronic inflammatory demyelinating polyneuropathy. Curr Opin Neurol 2017; 30: 508-512
• 4 Sinnreich M, Klein CJ, Daube JR. et al. Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia. Neurology 2004; 63: 1662-1669
• 5 EFNS-PNS Task Force. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First Revision. Eur J Neurol 2010; 17: 356-363
• 6 Gasparotti R, Padua L, Briani C. et al. New technologies for the assessment of neuropathies. Nat Rev Neurol 2017; 13: 203-216
• 7 Grimm A, Vittore D, Schubert V. et al. Ultrasound aspects in therapy-I CIDP compared to long-term treated CIDP. J Neurol 2016; 263: 1074-1082
• 8 Querol L, Devaux J, Rojas-Garcia R. et al. Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications. Nat Rev Neurol 2017; 13: 533-547
• 9 Mathey EK, Garg N, Park SB. et al. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies. J Neuroimmunol 2017; 309: 41-46
• 10 Mauermann ML. Paraproteinemic neuropathies. Continuum (Minneap Minn) 2014; 20: 1307-1322
• 11 Steck AJ, Stalder AK, Renaud S. Anti-myelin-associated glycoprotein neuropathy. Curr Opin Neurol 2006; 19: 458-463
• 12 Nobile-Orazio E, Gallia F. Multifocal motor neuropathy: current therapies and novel strategies. Drugs 2013; 73: 397-406
• 13 Rattay TW, Winter N, Décard B. et al. Nerve ultrasound as follow-up tool in treated multifocal motor neuropathy. Eur J Neurol 2017; 24: 1125-1134
• 14 Diener H-C. Leitlinien für Diagnostik und Therapie in der Neurologie. 5.. Aufl. Stuttgart: Thieme; 2012
• 15 Gwathmey KG, Burns TM, Collins MP. et al. Vasculitic neuropathies. Lancet Neurol 2014; 13: 67-82
• 16 Burns TM, Schaublin GA, Dyck PJB. Vasculitic neuropathies. Neurol Clin 2007; 25: 89-113
• 17 Blaes F. Diagnosis and therapeutic options for peripheral vasculitic neuropathy. Ther Adv Musculoskelet Dis 2015; 7: 45-55
• 18 Collins MP, Hadden RD. The nonsystemic vasculitic neuropathies. Nat Rev Neurol 2017; 13: 302-316
• 19 Grimm A, Décard BF, Bischof A. et al. Ultrasound of the peripheral nerves in systemic vasculitic neuropathies. J Neurol Sci 2014; 347: 44-44
• 20 Collins MP, Dyck PJB, Gronseth GS. et al. Peripheral Nerve Society: Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst 2010; 15: 176-184